84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]朱紫墨,楊延麟,汪利合.基于CiteSpace的仙靈骨葆臨床研究可視化分析[J].中醫(yī)正骨,2024,36(05):39-44.
　ZHU Zimo,YANG Yanlin,WANG Lihe.A CiteSpace-based visualization analysis of clinical research on Xianling Gubao(仙靈骨葆)[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(05):39-44.
點(diǎn)擊復(fù)制

基于CiteSpace的仙靈骨葆臨床研究可視化分析()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第36卷
期數(shù):
2024年05期
頁碼:
39-44
欄目:
文獻(xiàn)研究
出版日期:
2024-05-20

文章信息/Info

Title:
A CiteSpace-based visualization analysis of clinical research on Xianling Gubao(仙靈骨葆)
作者:
朱紫墨1; 楊延麟2; 汪利合3
1.河南中醫(yī)藥大學(xué)骨傷學(xué)院,河南 鄭州 450002; 2.河南理工大學(xué),河南 焦作 454000; 3.河南中醫(yī)藥大學(xué)第一附屬醫(yī)院,河南 鄭州 450000
Author(s):
ZHU Zimo1; YANG Yanlin2; WANG Lihe3
1.College of Orthopaedics and Traumatology of Henan University of Chinese Medicine,Zhengzhou 450002,Henan,China 2.Henan Polytechnic University,Jiaozuo 454000,Henan,China 3.The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450000,Henan,China
關(guān)鍵詞:
仙靈骨葆膠囊;  數(shù)據(jù)可視化;  聚類分析
Keywords:
Xian Ling Gu Bao Jiao Nang;  data visualization;  cluster analysis
摘要:
目的:通過CiteSpace可視化分析探究仙靈骨葆的臨床研究現(xiàn)狀與發(fā)展趨勢。方法:應(yīng)用計(jì)算機(jī)在中國知網(wǎng)中檢索關(guān)于仙靈骨葆的臨床研究文獻(xiàn),檢索年限為1991—2023年。根據(jù)文獻(xiàn)納入標(biāo)準(zhǔn)和排除標(biāo)準(zhǔn)篩選文獻(xiàn),將引文數(shù)據(jù)導(dǎo)入CiteSpace軟件,對年發(fā)文量、作者、機(jī)構(gòu)、關(guān)鍵詞等進(jìn)行可視化分析。結(jié)果:①一般結(jié)果。檢索獲得文獻(xiàn)848篇,最終納入文獻(xiàn)624篇,發(fā)表在233種期刊上,涉及作者1692位、機(jī)構(gòu)776家。②年發(fā)文量。1999—2005年,年發(fā)文量均在10篇以下,且波動(dòng)不大; 2006—2008年,年發(fā)文量呈快速上升趨勢; 2009—2013年,年發(fā)文量維持在20～30篇,呈小幅波動(dòng)趨勢; 2014—2017年,年發(fā)文量逐步增加,并在2017年達(dá)到峰值; 2018—2023年,年發(fā)文量呈波動(dòng)性下降趨勢。③作者。發(fā)文量較大的作者合作網(wǎng)絡(luò)分別是以史曉林為核心的合作網(wǎng)絡(luò)和包括史歷、侯欽午、馬俊嶺等的合作網(wǎng)絡(luò)。④機(jī)構(gòu)。發(fā)文量位于前5的機(jī)構(gòu)依次為浙江省麗水市中心醫(yī)院、廣州中醫(yī)藥大學(xué)第一附屬醫(yī)院、上海市浦東新區(qū)北蔡社區(qū)衛(wèi)生服務(wù)中心、浙江中醫(yī)藥大學(xué)第二附屬醫(yī)院、中國中醫(yī)科學(xué)院中醫(yī)臨床基礎(chǔ)醫(yī)學(xué)研究所。⑤關(guān)鍵詞。共現(xiàn)網(wǎng)絡(luò)分析結(jié)果顯示,突出節(jié)點(diǎn)有仙靈骨葆、骨質(zhì)疏松、骨密度、臨床觀察、臨床療效等; 頻次分析結(jié)果顯示,仙靈骨葆、骨質(zhì)疏松、骨密度、臨床觀察出現(xiàn)頻次較高; 聚類分析結(jié)果顯示,仙靈骨葆、骨質(zhì)疏松、骨折、骨密度聚類規(guī)模較大; 突現(xiàn)分析結(jié)果顯示,2005年前的突現(xiàn)詞為臨床觀察、中藥治療、骨復(fù)活湯,2006—2008年的突現(xiàn)詞為臨床研究、膝關(guān)節(jié)、骨關(guān)節(jié)炎等,2009—2017年的突現(xiàn)詞為玻璃酸鈉、骨折愈合、鈣爾奇D等,2018年后的突現(xiàn)詞為骨代謝、生活質(zhì)量、甲氨蝶呤等。結(jié)論:仙靈骨葆的臨床研究整體上處于穩(wěn)定發(fā)展中,出現(xiàn)了階段性的上升和下降; 研究團(tuán)隊(duì)較少,作者較為分散,團(tuán)隊(duì)之間合作不緊密; 研究機(jī)構(gòu)分布廣泛,機(jī)構(gòu)之間合作不緊密; 仙靈骨葆治療骨質(zhì)疏松的關(guān)注度較高; 探究仙靈骨葆影響骨代謝的作用機(jī)制可能是下一階段的研究方向。
Abstract:
Objective:To explore the clinical research status and trends of Xianling Gubao(仙靈骨葆,XLGB)through a CiteSpace-based visual analysis.Methods:The clinical research articles about XLGB included from 1991 to 2023 were retrieved from China National Knowledge Infrastructure through computer.The articles were screened according to the inclusion and exclusion criteria,and then the data from the included articles were imported into the CiteSpace software for visually analyzing the annual number of publications,authors,institutions,and keywords.Results:①Eight hundred and forty-eight articles were searched out.After screening,624 ones were included in the final analysis,involving 233 journals,1692 authors,and 776 institutions.②The annual number of publications was below 10 with slight fluctuations from 1999 to 2005,surged from 2006 to 2008,remained at 20-30 with slight fluctuations from 2009 to 2013,gradually increased from 2014 to 2017 and peaked in 2017,and declined with fluctuations from 2018 to 2023.③The author collaboration networks with a large number of publications were that centered around SHI Xiaolin and that including SHI Li,HOU Qinwu,and MA Junling.④The top 5 institutions with the largest number of publications were Lishui Central Hospital of Zhejiang Province,The First Affiliated Hospital of Guangzhou University of Chinese Medicine,Beicai Community Health Service Center in Pudong New Area of Shanghai,The Second Affiliated Hospital of Zhejiang Chinese Medical University,and Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences inturn.⑤The result of keyword co-occurrence network(KCN)analysis showed that the salient nodes included XLGB,osteoporosis(OP),bone mineral density(BMD),clinical observation,and clinical efficacy.The result of frequency analysis showed that XLGB,OP,BMD and clinical observation appeared more frequently.The cluster analysis revealed large clusters on XLGB,OP,fractures,and BMD.Furthermore,the keyword burst analysis indicated that the burst keywords were clinical observation,Chinese medicine treatment,and Gufuhuo Tang(骨復(fù)活湯)before 2005; clinical research,knee joint,and osteoarthritis during 2006-2008; sodium hyaluronate,fracture healing,and calcium carbonate and vitamin D3 tablets during 2009-2017; and bone metabolism,quality of life,and methotrexate after 2018.Conclusion:The clinical research on XLGB exhibits steady development in general,with phased rises and declines; meanwhile,less research teams are concerned on XLGB,with scattered authors and loose collaboration between teams; besides,the related research institutions are wide-spreading with loose collaboration.XLGB has attracted more attention in treatment of OP,and its mechanism(s)involved in regulating bone metabolism may be a future research orientation.

參考文獻(xiàn)/References:

[1] 邢燕,畢宏焱,張倩楠,等.骨質(zhì)疏松常用中成藥介紹[J].中國骨質(zhì)疏松雜志,2013,19(1):83-85.
[2] 李杰,陳超美.CiteSpace科技文本挖掘及可視化[M].3版.北京:首都經(jīng)濟(jì)貿(mào)易大學(xué)出版社,2022:3.
[3] 王眠龍.仙靈骨葆膠囊治療骨質(zhì)疏松癥導(dǎo)致腰腿痛的典型病例報(bào)告[J].海峽藥學(xué),1999,11(S2):92-93.
[4] 胡彩仙,程梅芬.仙靈骨葆膠囊治療骨質(zhì)疏松癥30例的臨床觀察[J].中成藥,2000,22(3):246-247.
[5] 方向明,王蓬華,楊強(qiáng).仙靈骨葆治療老年性骨質(zhì)疏松癥的療效觀察[J].現(xiàn)代康復(fù),2001,5(6):87.
[6] 邵光湘,韓銘,韓琳.仙靈骨葆膠囊治療酒精性股骨頭壞死的臨床觀察[J].中國中醫(yī)骨傷科雜志,2006,14(S2):106-108.
[7] 尚玉敏,劉艷艷,李惠萍.仙靈骨葆膠囊治療絕經(jīng)后骨質(zhì)疏松癥的臨床觀察[J].中國中西醫(yī)結(jié)合急救雜志,2007,14(1):55.
[8] 吳鵬強(qiáng),徐花蘭.仙靈骨葆膠囊防治老年性胸腰椎骨質(zhì)疏松癥[J].浙江中西醫(yī)結(jié)合雜志,2007,17(7):429-430.
[9] 吳劍,鮑同柱,鄢飛,等.梔子粉外敷加仙靈骨葆治療膝骨性關(guān)節(jié)炎[J].山東中醫(yī)雜志,2008,27(9):594-595.
[10] 崔書國,趙建,崔喜雙.仙靈骨葆配合中藥熏洗治療膝骨性關(guān)節(jié)炎60例[J].河北中醫(yī)藥學(xué)報(bào),2008,23(3):26-27.
[11] 魏書亭.仙靈骨葆膠囊配合阿倫磷酸鈉治療原發(fā)性骨質(zhì)疏松癥98例療效觀察[J].亞太傳統(tǒng)醫(yī)藥,2013,9(1):173-174.
[12] 趙楊,王廣宏.仙靈骨葆聯(lián)合玻璃酸鈉治療膝關(guān)節(jié)骨性關(guān)節(jié)炎的臨床觀察[J].中醫(yī)藥信息,2011,28(4):86-87.
[13] 邵亞超.仙靈骨葆聯(lián)合玻璃酸鈉治療膝骨性關(guān)節(jié)炎46例[J].中國藥業(yè),2015,24(4):88.
[14] 陳少初,胡益雄,賴俊成,等.醫(yī)用臭氧聯(lián)合仙靈骨葆膠囊治療膝骨性關(guān)節(jié)炎40例療效觀察[J].海南醫(yī)學(xué),2013,24(7):960-963.
[15] 鐘芳曉,王武琦.仙靈骨葆膠囊聯(lián)合醫(yī)用臭氧對膝骨性關(guān)節(jié)炎疼痛及膝關(guān)節(jié)功能影響的分析[J].新中醫(yī),2015,47(8):120-122.
[16] 吳中琴.仙靈骨葆膠囊合用鈣爾奇D治療女性絕經(jīng)后骨質(zhì)疏松癥的療效觀察[J].海峽藥學(xué),2010,22(12):159-160.
[17] 馮炎林,陳文欽,吳奮飛.仙靈骨葆、福善美聯(lián)合鈣爾奇D治療骨質(zhì)疏松的效果比較[J].海峽藥學(xué),2013,25(6):163-164.
[18] 鮑軍國,李新春.仙靈骨葆膠囊聯(lián)合鈣爾奇D和阿侖膦酸鈉片治療老年骨質(zhì)疏松的療效比較研究[J].遼寧中醫(yī)雜志,2015,42(4):784-785.
[19] 汪發(fā)蓮,楊生仁,李舜君,等.仙靈骨葆膠囊聯(lián)合阿侖膦酸鈉對骨質(zhì)疏松癥患者的骨代謝及骨轉(zhuǎn)換指標(biāo)的影響[J].藥物評價(jià)研究,2020,43(11):2259-2262.
[20] 吳耀華,吳稀民,付遠(yuǎn)亮,等.仙靈骨葆膠囊治療骨質(zhì)疏松癥的療效及對骨密度、骨代謝的影響[J].北方藥學(xué),2022,19(7):65-67.
[21] 潘方瑛,張健兒,鄭美暄.仙靈骨葆膠囊聯(lián)合唑來膦酸鹽、鈣爾奇D治療骨質(zhì)疏松癥療效觀察及對骨代謝指標(biāo)的影響[J].新中醫(yī),2022,54(11):138-141.
[22] 酈妙爾,蘇進(jìn)展,宋俠,等.基于定量CT評價(jià)仙靈骨葆膠囊治療骨質(zhì)疏松的療效分析[J].中國中醫(yī)藥科技,2023,30(5):884-886.

備注/Memo

備注/Memo:
基金項(xiàng)目:河南省中醫(yī)藥拔尖人才培養(yǎng)項(xiàng)目(豫中醫(yī)科教〔2018〕35號(hào))
通訊作者:楊延麟 E-mail:[email protected]
更新日期/Last Update: 1900-01-01